Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders

References

• Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release. 2010;141(3):277–299.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M. Handbook of experimental pharmacology: drug delivery. Heidelberg: Springer; 2010.
   Google Scholar
• Jain KK. Drug delivery systems. Totowa: Humana Press; 2008.
   Google Scholar
• Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223.
   PubMed Web of Science ®Google Scholar
• Sezer AD. Recent advances in novel drug carrier systems. Rijeka: InTech; 2012.
   Google Scholar
• Zhang Z, Tsai PC, Ramezanli T, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(3):205–218.
   PubMed Web of Science ®Google Scholar
• Pierre MB, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303(9):607–621.
   PubMed Web of Science ®Google Scholar
• Aparajita V, Ravikumar P. Liposomes as carriers in skin ageing. Int J Curr Pharm Res. 2014;6(3):1–7.
   Google Scholar
• Maheshwari RG, Tekade RK, Sharma PA, et al. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J. 2012;20(2):161–170.
   PubMed Web of Science ®Google Scholar
• Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012;8(1):47–69.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170(3):380–395.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Mezei M, Gulasekharam V. Liposomes – a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci. 1980;26(18):1473–1477.
   PubMed Web of Science ®Google Scholar
• Frolov VA, Shnyrova AV, Zimmerberg J. Lipid polymorphisms and membrane shape. Cold Spring Harb Perspect Biol. 2011;3(11):a004747.
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115(19):10938–10966.
   PubMed Web of Science ®Google Scholar
• Etheridge ML, Campbell SA, Erdman AG, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013;9(1):1–14.
   PubMed Web of Science ®Google Scholar
• López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 2005;298(1):1–12.
   PubMed Web of Science ®Google Scholar
• Mozafari MR. Nanomaterials and nanosystems for biomedical applications. Dordrecht: Springer; 2007.
   Google Scholar
• Simon SA, McIntosh TJ. Depth of water penetration into lipid bilayers. Methods Enzymol. 1986;127:511–521.
   PubMed Web of Science ®Google Scholar
• Socaciu C, Jessel R, Diehl HA. Competitive carotenoid and cholesterol incorporation into liposomes: effects on membrane phase transition, fluidity, polarity and anisotropy. Chem Phys Lipids. 2000;106(1):79–88.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1(3):297–315.
   PubMed Web of Science ®Google Scholar
• Shi K, Li J, Cao Z, et al. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin alphavbeta3 for the treatment of melanoma. J Control Release. 2015;217:138–150.
   PubMed Web of Science ®Google Scholar
• Kwon SS, Kim SY, Kong BJ, et al. Cell penetrating peptide conjugated liposomes as transdermal delivery system of Polygonum aviculare L. Extract. Int J Pharm. 2015;483(1–2):26–37.
   PubMed Web of Science ®Google Scholar
• Desai P, Patlolla RR, Singh M. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol. 2010;27(7):247–259.
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9(2):223–243.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 2008;34(4–5):203–222.
   PubMed Web of Science ®Google Scholar
• Florence AT. Liposomes in drug delivery. London: Taylor & Francis; 1993.
   Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–999.
   PubMed Web of Science ®Google Scholar
• Domb AJ, Khan W. Focal controlled drug delivery. New York: Springer Science & Business Media; 2014.
   Google Scholar
• Colosé. Colosé liposome gel. 2016. [cited 2016 Feb 26]. Available from: colose.luondo.nl/1808258/liposome–gel.
   Google Scholar
• Chemisches Laboratorium Dr. Kurt Richter. MPC-liposomes. 2016. [cited 2016 Mar 10]. Available from: www.clr-berlin.com/index.php?article_id=12&clang=1&selection=2&product=21.
   Google Scholar
• Heliotrop. Multiactive – because demanding skin needs a little extra care. 2014. [cited 2015 Sep 3]. Available from: www.heliotrop.de/en/products/face/demanding-skin/.
   Google Scholar
• Rieger M, Rhein LD. Surfactants in cosmetics. 2nd ed. London: Taylor & Francis; 1997.
   Google Scholar
• MSM Cream. Source naturals. 2015. [cited 2015 Aug 31]. Available from: www.sourcenaturals.com/products/GP1222.
   Google Scholar
• Cosme Decorte products. Cosme decorte. 2016. [cited 2016 Mar 10]. Available from: www.cosme-de.com/en/product/search_results.html?srchstr=liposome&bpid=b00000222.
   Google Scholar
• Dr. Baumann. SkinIdent – the nature of skin. 2015. [cited 2015 Sep 3]. Available from: www.dr-baumann.com/en/home.
   Google Scholar
• Babor. Babor whitening – brightens the skin quickly and effectively. 2015. [cited 2015 Sep 2]. Available from: www.babor.com.sg/L/0/Whitening.4532.0.html.
   Google Scholar
• SEQuaderma. Pro Bono Bio. 2016. [cited 2016 Mar 9]. Available from: www.sequaderma.com.
   Google Scholar
• Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 2010;1(3):274–282.
   PubMedGoogle Scholar
• Prasad SS, Parthiban S, Senthil Kumar SK. Ethosomes as drug carrier: a novel approach. IJIDD. 2013;3(2):55–66.
   Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–184.
   PubMed Web of Science ®Google Scholar
• Singhal GB, Patel RP, Prajapati BG, et al. Solid lipid nanoparticles and nano lipid carriers: as novel solid lipid based drug carrier. IRJP. 2011;2(2):40–52.
   Google Scholar
• Applied Genetics. T4N5 liposome lotion compared with placebo lotion for preventing actinic keratoses in patients with xeroderma pigmentosum. In: ClinicalTrials.gov. Identifier: NCT00002811. [cited 2016 Mar 10]. Available from: clinicaltrials.gov/ct2/show/NCT00002811.
   Google Scholar
• Rahman SA, Abdelmalak NS, Badawi A, et al. Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients. Drug Deliv. 2016;23(4):1184–1193.
   PubMed Web of Science ®Google Scholar
• National University Hospital, Singapore. The efficacy and safety of 3% povidone-iodine in acne therapy. In: ClinicalTrials.gov. Identifier: NCT02126709. [cited 2016 Mar 10]. Available from: clinicaltrials.gov/ct2/show/NCT02126709.
   Google Scholar
• Research and Markets. TDT-067 (dermatophytic onychomycosis) – forecast and market analysis to 2022. 2013. [cited 2016 Jan 18]. Available from: www.researchandmarkets.com/research/7hk5wz/tdt067.
   Google Scholar
• Sigurgeirsson B, Ghannoum M. Therapeutic potential of TDT 067 (terbinafine in transfersome): a carrier-based dosage form of terbinafine for onychomycosis. Expert Opin Investig Drugs. 2012;21(10):1549–1562.
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, et al. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1–2):99–110.
   PubMed Web of Science ®Google Scholar
• Lakshmi PK, Devi GS, Bhaskaran S, et al. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol. 2007;73(3):157–161.
   PubMed Web of Science ®Google Scholar
• Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel – an adjuvant in the treatment of psoriasis. Int J Pharm Sci Rev Res. 2011;7(1):1–7.
   Google Scholar
• Bendas ER, Abdullah H, El-Komy MH, et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm. 2013;458(2):287–295.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release. 2012;164(1):17–25.
   PubMed Web of Science ®Google Scholar
• Paolino D, Muzzalupo R, Ricciardi A, et al. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Biomed Microdevices. 2007;9(4):421–433.
   PubMed Web of Science ®Google Scholar
• Manosroi J, Khositsuntiwong N, Manosroi A. Performance test of gel containing extracts from Thai Lanna medicinal plants entrapped in niosomes for hair loss treatment. J Thai Tradit Altern Med. 2008;6(2):1.
   PubMedGoogle Scholar
• Manosroi A, Chutoprapat R, Abe M, et al. Anti-aging efficacy of topical formulations containing niosomes entrapped with rice bran bioactive compounds. Pharm Biol. 2012;50(2):208–224.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Jantrawut P, Akihisa T, et al. In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol. 2011;49(11):1190–1203.
   PubMed Web of Science ®Google Scholar
• Guan Y, Zuo T, Chang M, et al. Propranolol hydrochloride-loaded liposomal gel for transdermal delivery: characterization and in vivo evaluation. Int J Pharm. 2015;487(1–2):135–141.
   PubMed Web of Science ®Google Scholar
• Eroglu I, Azizoglu E, Ozyazici M, et al. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations. Drug Deliv. 2016;23(5):1502–1513.
   PubMed Web of Science ®Google Scholar
• Oh EK, Jin SE, Kim JK, et al. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci. 2011;44(1–2):149–157.
   PubMed Web of Science ®Google Scholar
• Dorrani M, Garbuzenko OB, Minko T, et al. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J Control Release. 2016;228:150–158.
   PubMed Web of Science ®Google Scholar
• Zhang YT, Shen LN, Wu ZH, et al. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 2014;471(1–2):449–452.
   PubMed Web of Science ®Google Scholar
• Desmet E, Bracke S, Forier K, et al. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: proof-of-concept in the treatment of psoriasis. Int J Pharm. 2016;500(1–2):268–274.
   PubMed Web of Science ®Google Scholar
• Bracke S, Carretero M, Guerrero-Aspizua S, et al. Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies. Exp Dermatol. 2014;23(3):199–201.
   PubMed Web of Science ®Google Scholar
• Geusens B, Van Gele M, Braat S, et al. Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin. Adv Funct Mater. 2010;20(23):4077–4090.
   Web of Science ®Google Scholar
• Guo F, Wang J, Ma M, et al. Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation. J Mater Sci Mater Med. 2015;26(4):175.
   PubMed Web of Science ®Google Scholar
• Andrade LM, de Fátima Reis C, Maione-Silva L, et al. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2014;88(1):40–47.
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 2012;165(4):454–461.
   PubMed Web of Science ®Google Scholar
• Chen YC, Liu DZ, Liu JJ, et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. Int J Nanomed. 2012;7:4409–4418.
   PubMed Web of Science ®Google Scholar
• Pando D, Matos M, Gutiérrez G, et al. Formulation of resveratrol entrapped niosomes for topical use. Colloids Surf B Biointerfaces. 2015;128:398–404.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, AbouGhaly MHH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1–2):235–243.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sinha VR. Design, development and characterization of topical microemulsions of 5-fluorouracil for the treatment of non melanoma skin cancer and its precursor lesions. Anticancer Agents Med Chem. 2015;16(2):259–268.
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, et al. Novel isotretinoin microemulsion-based gel for targeted topical therapy of acne: formulation consideration, skin retention and skin irritation studies. Appl Nanosci. 2016;6:539–553.
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Parikh JR, et al. Novel microemulsion-based gel formulation of tazarotene for therapy of acne. Pharm Dev Technol. 2015;1–12. doi:10.3109/10837450.2015.1081610. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Sarmah PJ, Kalita B, Sharma AK. Transfersomes based transdermal drug delivery: an overview. IJAPR. 2013;4(12):2555–2563.
   Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104(1):226–232.
   PubMed Web of Science ®Google Scholar
• Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23–33.
   PubMedGoogle Scholar
• Rajan R, Jose S, Mukund VP, et al. Transferosomes – a vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2011;2(3):138–143.
   PubMedGoogle Scholar
• Maurya SD, Agarwal S, Tilak VK, et al. Enhanced transdermal delivery of indinavir sulfate via transferosomes. Int J Compr Pharm. 2010;1:1–7.
   Google Scholar
• Pro Bono Bio. Apply FLEXISEQ for joint pain relief: it works like topical biolubricant implant on affected joint pain areas. 2014. [cited 2016 Jan 7]. Available from: www.flexiseq.com.sg/news.
   Google Scholar
• Sequessome technology. Trademark hound LLC. 2012. [cited 2015 Jun 16]. Available from: www.markhound.com/trademark/search/3vP1qsDCj.
   Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65(3):403–418.
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 2007;123(2):148–154.
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Caddeo C, et al. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 2011;412(1–2):37–46.
   PubMed Web of Science ®Google Scholar
• Verma DD, Fahr A. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release. 2004;97(1):55–66.
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412–9420.
   PubMed Web of Science ®Google Scholar
• McKelvey KJ, Powell KL, Ashton AW, et al. Exosomes: mechanisms of uptake. J Circ Biomark. 2015;4(7). doi:10.5772/61186.
   Google Scholar
• Record M, Carayon K, Poirot M, et al. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014;1841(1):108–120.
   PubMed Web of Science ®Google Scholar
• Record M, Subra C, Silvente-Poirot S, et al. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol. 2011;81(10):1171–1182.
   PubMed Web of Science ®Google Scholar
• De Toro J, Herschlik L, Waldner C, et al. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015;6:203.
   PubMed Web of Science ®Google Scholar
• Kooijmans SA, Vader P, Van Dommelen SM, et al. Exosome mimetics: a novel class of drug delivery systems. Int J Nanomed. 2012;7:1525–1541.
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, et al. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles. Int J Nanomed. 2007;2(4):595–607.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349–358.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting H-C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59(6):427–443.
   PubMed Web of Science ®Google Scholar
• Madhav NVS, Saini A. Niosomes: a novel drug delivery system. IJRPC. 2011;1:498–511.
   Google Scholar
• Pola Chandu V, Arunachalam A, Jeganath S, et al. Niosomes: a novel drug delivery system. IJNTPS. 2012;2(1):25–31.
   Google Scholar
• Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol. 2006;19(1):2–16.
   PubMed Web of Science ®Google Scholar
• Azmin MN, Florence AT, Handjani-Vila RM, et al. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol. 1985;37(4):237–242.
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25(7):499–512.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Rahimpour Y, Kouhsoltani M. Niosomes as a propitious carrier for topical drug delivery. Expert Opin Drug Deliv. 2013;10(2):261–272.
   PubMed Web of Science ®Google Scholar
• Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target. 2009;17(9):671–689.
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm. 2000;206(1–2):110–122.
   PubMed Web of Science ®Google Scholar
• Handjani-Vila RM, Ribier A, Rondot B, et al. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci. 1979;1(5):303–314.
   PubMed Web of Science ®Google Scholar
• L’Oréal. Niosôme by Lancôme: a major advance in anti-aging. 2012. [cited 2015 Sep 14]. Available from: www.lorealusa.com/Article.aspx?topcode=CorpTopic_Group_History_19842000_1986.
   Google Scholar
• Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev. 2002;54 Suppl 1:S77–S98.
   PubMed Web of Science ®Google Scholar
• Devarajan PV, Jain S. Targeted drug delivery: concepts and design. Cham: Springer International Publishing; 2014.
   Google Scholar
• Midler O. Microemulsions as drug delivery systems. 2003 [cited 2015 Sep 15]. Available from: http://www.vetcontact.com/presentations/midler1/abstracts/midler.pdf.
   Google Scholar
• Singh V, Kataria MK, Bilandi A, et al. Recent advances in pharmaceutical emulsion technology. JPR. 2012;5(8):4250–4258.
   Google Scholar
• MediQuest Therapeutics. MQT – controlling inflammation and infection topically: our technology and products. 2008. [cited 2015 Oct 29]. Available from: www.mqti.com/technology.php.
   Google Scholar